CAMBRIDGE, Mass., Jan. 12, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today reported on its 2008 R&D and business progress, announced its key 2009 objectives, and introduced its I4 2012 goals. Infinity's I4 2012 goals are the four major strategic objectives the company anticipates achieving by the end of 2012.
